Functional genomics Functional variant assays: abnormal biology is not automatically pathogenicity October 22, 2026 Medical Genetics editorial team Comments Off on Functional variant assays: abnormal biology is not automatically pathogenicity Read functional variant evidence critically: calibration, PS3/BS3, BRCA1 experiments and what a normal or abnormal assay can miss. […]
Epigenetics DNA methylation episignatures: biomarkers with a defined scope October 22, 2026 Medical Genetics editorial team Comments Off on DNA methylation episignatures: biomarkers with a defined scope A reproducible methylation pattern can support a diagnosis, but classifier coverage and validation determine how much it can resolve. […]
Functional genomics Single-cell genomics: more cells do not replace more participants October 22, 2026 Medical Genetics editorial team Comments Off on Single-cell genomics: more cells do not replace more participants Learn why donor numbers matter in single-cell studies, with a worked example, pseudobulk comparison and checks for confounding. […]
Genomic technologies Long-read sequencing after a negative genetic test: what can it add? October 22, 2026 Medical Genetics editorial team Comments Off on Long-read sequencing after a negative genetic test: what can it add? Understand when long-read sequencing may help after an inconclusive test, with examples of phase, repeat expansions and diagnostic-yield claims. […]
Molecular diagnostics Clinical RNA sequencing: what it can reveal after a genetic test October 22, 2026 Medical Genetics editorial team Comments Off on Clinical RNA sequencing: what it can reveal after a genetic test Learn what RNA sequencing can reveal about splicing and expression, with practical examples, tissue limitations and evidence from long-read RNA studies. […]
Genomic testing Trio sequencing: what parents’ samples can reveal about a genetic result October 22, 2026 Medical Genetics editorial team Comments Off on Trio sequencing: what parents’ samples can reveal about a genetic result Explore trio sequencing with examples of de novo variants, recessive inheritance and unaffected parents, plus questions about consent and follow-up. […]
Cancer Genetics Tumour vs germline testing: how to resolve discordant reports October 22, 2026 Medical Genetics editorial team Comments Off on Tumour vs germline testing: how to resolve discordant reports Why tumour and germline reports can differ, when genetics input helps, and what information makes a useful referral. Includes practical examples. […]
Complex disease genetics Polygenic risk scores: how to read a result and judge the evidence October 22, 2026 Medical Genetics editorial team Comments Off on Polygenic risk scores: how to read a result and judge the evidence Understand polygenic risk scores with practical examples of percentiles, calibration and clinical usefulness, plus a checklist for reviewing research. […]
Inheritance Penetrance vs expressivity: the difference, with examples October 22, 2026 Medical Genetics editorial team Comments Off on Penetrance vs expressivity: the difference, with examples Learn how penetrance differs from expressivity, why age matters, and why inheriting a variant is not the same as developing a condition. […]
Clinical research Rare-disease trial endpoints: measure a change that matters October 22, 2026 Medical Genetics editorial team Comments Off on Rare-disease trial endpoints: measure a change that matters Small populations make endpoint selection more demanding, not less; connect measurement quality, natural history and patient relevance. […]